Genetics
Vitamin D, Body Mass Index, and Multiple Sclerosis: Genetic Evidence for Disease Risk and Relapse Hazard30, May 2026
28, May 2026
Alper Bülbül
30, May 2026
This blog post examines the Mendelian randomization study by Vandebergh, Dubois, and Goris, which investigates whether serum 25-hydroxyvitamin D levels and body mass index causally influence multiple sclerosis risk and relapse hazard. The article highlights that genetically predicted higher vitamin D levels are associated with reduced multiple sclerosis susceptibility and lower relapse hazard after disease onset, whereas higher body mass index increases disease risk but does not show clear evidence of affecting relapse occurrence.
Read more28, May 2026
